Litcius/Paper detail

In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals

Sachin Bhagwat, N.J. Legakis, Tilemachos Skalidis, Anastassios Loannidis, Christos Goumenopoulos, Prashant Joshi, Rahul Shrivastava, Snehal Palwe, Hariharan Periasamy, Mahesh Patel, Stylianos Chatzipanagiotou

2021Diagnostic Microbiology and Infectious Disease18 citationsDOI

Topics & Concepts

CefepimeAcinetobacter baumanniiColistinBroth microdilutionTigecyclineMicrobiologyImipenemCeftazidime/avibactamCeftazidimeBiologyMedicineAntibioticsAntibiotic resistancePseudomonas aeruginosaMinimum inhibitory concentrationBacteriaGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals | Litcius